SATB2 and malignant colon neoplasm: It is evolutionarily conserved that the AT-rich sequence binding protein 2 (SATB2) plays a role in transcription. High SATB2 expression has been shown to predict good outcomes in colon cancer and modulate chemotherapy and radiation sensitivity [54].